US$ 22.80
fda bpc-157 unapproved drug warning is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA Issues Five Warning Letters
Description
That thinness is great for painless injections, but it makes drawing trickier than most beginners expect

So why do most serious researchers still go with injectable

Typical daily range: 400 mcg (0.4 mg) 1,200 mcg (1.2 mg) total blend once daily, raised gradually across the cycle

The debate between BPC 157 nasal spray vs injection comes up a lot in the peptide world
